A
AIM ImmunoTech
AIM
0.34400
USD
-0.015
(-4.18%)
مغلق
حجم التداول
743
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
14,906,960
العنوان: AIM ImmunoTech
القطاع: Healthcare
الصناعة: Biotechnology
AIM ImmunoTech Inc is an immuno-pharma company focused on research and development of therapeutics to treat immune disorders and viral and cancer diseases. AIM's flagship products include Ampligen (Rintatolimod), a drug of large macromolecular RNA molecules for cancer and viral diseases, and the drug Alferon N Injection for a category of STD infection. Clinical trials of Ampligen include studies of cancer patients with renal cell carcinoma, malignant melanoma, colorectal cancer, advanced recurrent ovarian cancer, and triple-negative metastatic breast cancer. It is also advancing Ampligen as a potential treatment for COVID-19. FDA has authorized the first human trial assessing the safety and effectiveness of Ampligen in combination with interferon alfa-2b, in cancer patients with COVID-19.